Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Conditions
- Gastrinoma
- Glucagonoma
- Insulinoma
- Pancreatic Polypeptide Tumor
- Recurrent Islet Cell Carcinoma
- Recurrent Pancreatic Cancer
- Somatostatinoma
- Stage III Pancreatic Cancer
- Stage IV Pancreatic Cancer
Interventions
- DRUG: Capecitabine
- DRUG: Temozolomide
- BIOLOGICAL: Bevacizumab
Sponsor
Shaheen Shagufta
Collaborators